Home › NDC Lookup › RxCUI directory › RxCUI 904630

10 ML sotalol hydrochloride 15 MG/ML Injection — RxCUI 904630

RxNorm drug concept · Semantic clinical drug
RxCUI 904630 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI904630
Official name10 ML sotalol hydrochloride 15 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assotalol hydrochloride 150 MG per 10 ML Injection; sotalol HCl 150 MG in 10 ML Injection
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Sotalol: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • That's a fair question — and I understand it feels like a lot. The reason is that sotalol can actually trigger the very type of dangerous heart rhythm it's supposed to treat, espec...
  • Why do I have to start this medicine in the hospital? Can't I just take it at home?
  • Some things like mild fatigue, a slightly slower heart rate, or feeling a bit lightheaded are common and often settle down. But there are symptoms you should never sit on — if you...
  • What side effects should I just ride out, and which ones mean I need to call for help right away?
📖 Read our full Sotalol guide →

🕸️ Concept Web — How 10 ML sotalol hydrochloride 15 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 10 ML sotalol hydrochloride 15 MG/ML Injection RxCUI 904630

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Sotalol 9947
    • Sotalol hydrochloride 7008
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Sotalol Injection 1721605
    • Sotalol hydrochloride Injection 2648168
    • Sotalol Injectable Product 1161103
    • Sotalol hydrochloride Injectable Product 2659379
    • Injection 1649574
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Sotalol hydrochloride 15 MG/ML 904629

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Sotalol hydrochloride 15 MG/ML SCDC · 904629
  • Sotalol Injection SCDF · 1721605
  • Sotalol hydrochloride Injection SCDFP · 2648168
  • Sotalol Injectable Product SCDG · 1161103
  • Sotalol hydrochloride Injectable Product SCDGP · 2659379

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 904630 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
69724-0112-10 1 VIAL in 1 CARTON (69724-112-10) / 10 mL in 1 VIAL Sotalol hydrochloride ALTATHERA Pharmaceuticals, LLC 2015-10-15
Observed labelers: ALTATHERA Pharmaceuticals, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.